U.S. markets closed
  • S&P Futures

    3,806.75
    -10.00 (-0.26%)
     
  • Dow Futures

    31,194.00
    -42.00 (-0.13%)
     
  • Nasdaq Futures

    12,627.25
    -54.50 (-0.43%)
     
  • Russell 2000 Futures

    2,196.10
    -9.70 (-0.44%)
     
  • Crude Oil

    61.28
    0.00 (0.00%)
     
  • Gold

    1,712.30
    -3.50 (-0.20%)
     
  • Silver

    26.25
    -0.14 (-0.52%)
     
  • EUR/USD

    1.2055
    -0.0012 (-0.10%)
     
  • 10-Yr Bond

    1.4700
    +0.0550 (+3.89%)
     
  • Vix

    26.67
    +2.57 (+10.66%)
     
  • GBP/USD

    1.3927
    -0.0025 (-0.18%)
     
  • USD/JPY

    107.0850
    +0.0830 (+0.08%)
     
  • BTC-USD

    51,540.95
    +2,845.35 (+5.84%)
     
  • CMC Crypto 200

    1,029.74
    +41.65 (+4.22%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,127.10
    -432.00 (-1.46%)
     

Recap: Agilent Technologies Q1 Earnings

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Agilent Technologies (NYSE:A) moved higher after the company reported Q1 results.

Quarterly Results

Earnings per share rose 30.86% over the past year to $1.06, which beat the estimate of $0.89.

Revenue of $1,548,000,000 rose by 14.08% year over year, which beat the estimate of $1,440,000,000.

Guidance

Agilent Sees Q2 Adj. EPS $0.78-$0.80 vs $0.83 Estimate, Sales $1.37B-$1.39B vs $1.36B Est.

Details Of The Call

Date: Feb 16, 2021

Time: 04:30 PM

View more earnings on A

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fwww.investor.agilent.com%2F&eventid=2948473&sessionid=1&key=D402A10AF84142954B515A498EE21495&regTag=&V2=false&sourcepage=register

Recent Stock Performance

Company's 52-week high was at $129.34

52-week low: $61.13

Price action over last quarter: Up 11.75%

Company Overview

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2019 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (31%) and China (20%) representing the largest country concentrations.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.